Correction to: Adv Rheumatol 64, 48 (2024)
10.1186/s42358-024-00386-8
The original publication of this article contained an error in Tables 1 and 2 related to the activity index and the level of agreement. Only the incorrect and correct columns/rows of the table are shown in this correction article, the full tables can be accessed via the original article. The original article has been updated.
Incorrect cells Table 1
|
Activity Index (0–24) • Endocapillary hypercellularity • Neutrophils and/or karyorrhexis • Hyaline deposits (x2) • Fibrinoid necrosis (x2) • Cellular/fibrocellular crescents • Interstitial inflammation |
Chronicity index (0–12) • Total glomerular sclerosis • Fibrous crescents • Interstitial fibrosis • Tubular atrophy |
Score • 0: Absent • 1: <25% • 2: 25–50% • 3: >50% |
Correct cells Table 1
|
Activity Index (0–24) • Endocapillary hypercellularity • Neutrophils and/or karyorrhexis • Hyaline deposits • Fibrinoid necrosis (x2) • Cellular/fibrocellular crescents (x2) • Interstitial inflammation |
Chronicity index (0–12) • Total glomerular sclerosis • Fibrous crescents • Interstitial fibrosis • Tubular atrophy |
Score • 0: Absent • 1: <25% • 2: 25–50% • 3: >50% |
Incorrect cells Table 2
| Recommendation | Level of agreement |
|---|---|
| Induction therapy | |
| 8. CsA as immunosuppressant in monotherapy is not recommended for induction therapy | 88.2% |
| 9. LFN as immunosuppressant in monotherapy is not recommended for induction therapy | 82.3% |
| 10. Monthly glucocorticoid pulse therapy is not recommended during induction therapy | 88.9% |
Correct cells Table 2
| Recommendation | Level of agreement |
|---|---|
| Induction therapy | |
| 8. CsA as immunosuppressant in monotherapy is not recommended for induction therapy | 82.3% |
| 9. LFN as immunosuppressant in monotherapy is not recommended for induction therapy | 88.9% |
| 10. Monthly glucocorticoid pulse therapy is not recommended during induction therapy | 88.2% |
Footnotes
The online version of the original article can be found at 10.1186/s42358-024-00386-8.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edgard Torres dos Reis-Neto and Luciana Parente Costa Seguro are first authors and contributed equally to this work.